• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,200.68 -893.39
( -1.16%)
Global Indices
Nasdaq
51,748.06 162.36
(0.31%)
Dow Jones
7,496.17 -25.41
(-0.34%)
Hang Seng
70,132.76 -2,221.20
(-3.07%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.32 -0.07
(-0.07%)
EUR-INR
108.15 -0.25
(-0.23%)
GBP-INR
124.70 -0.38
(-0.31%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Iware Supplychain Services Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
94355
INE1AII01014
52.0026129
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IWARE
25.95
391.03
EPS(TTM)
Face Value()
Div & Yield %
14.06
10
0.27
 

Jubilant Pharmova's Spokane facility gets USFDA inspection with 8 observations
Jun 19,2026
The inspection concluded with eight observations issued by the USFDA, none of which are related to sterility assurance concerns. The company said it will respond to the observations within 15 business days and remains committed to addressing them comprehensively.

Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of Jubilant Pharmova.

Jubilant Pharmova is an integrated global pharmaceutical company with three business segments, namely pharmaceuticals, contract research and development services, and proprietary novel drugs. The company’s consolidated net profit declined 22.27% to Rs 119.40 crore, while net sales rose 18.60% to Rs 2,272.20 crore in Q4 FY26 compared with Q4 FY25.

Shares of Jubilant Pharmova shed 0.94% to Rs 965.45 on the BSE.